Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
| 07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
|---|---|---|---|---|---|
| Net Income | 43.35% | 84.99% | 86.08% | 80.79% | 55.96% |
| Total Depreciation and Amortization | 1.22% | -7.00% | -5.54% | 2.48% | 43.03% |
| Total Amortization of Deferred Charges | -45.54% | 2,136.74% | 75.00% | 74.94% | 148.45% |
| Total Other Non-Cash Items | -76.15% | -74.05% | -55.34% | -59.64% | -36.58% |
| Change in Net Operating Assets | 86.05% | -105.02% | -138.12% | -108.81% | -60.86% |
| Cash from Operations | -12.50% | 431.86% | 310.19% | 260.37% | 156.18% |
| Capital Expenditure | 53.71% | -72.34% | 5.75% | 0.20% | 58.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 200.08% |
| Cash from Investing | -1.43% | -72.34% | 5.75% | 0.20% | 84.64% |
| Total Debt Issued | -73.74% | -101.96% | -78.15% | -79.03% | 19.58% |
| Total Debt Repaid | 70.88% | -53.26% | -73.21% | -84.05% | -1,649.14% |
| Issuance of Common Stock | -86.72% | 3,492.62% | 744.52% | 383.82% | 327.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.48% | -185.66% | -702.33% | -526.21% | -211.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.03% | 99.57% | 100.67% | 102.76% | -26.74% |